Graded Exposure Therapy in Women With Chronic Pelvic Pain
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Chronic Pelvic Pain
- Sponsor
- Universidad de Granada
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Fear-avoidance behaviors
- Last Updated
- 7 years ago
Overview
Brief Summary
Chronic pelvic pain (CPP) is considered as nonmalignant recurrent or continuous pain related to the structures of the pelvis. The objective of this study was to evaluate the effects of graded exposure therapy in women with chronic pelvic pain.
Detailed Description
Chronic pelvic pain (CPP) is considered as nonmalignant recurrent or continuous pain related to the structures of the pelvis. This condition lasts at least 6 months, and many times is associated with negative cognitive, emotional, sexual and behavioral consequences.In addition to the high economic cost, CPP is also costly in emotional and psychological suffering. This clinical trial aims to evaluate the effects of a program based on graded exposure therapy in women with chronic pelvic pain.
Investigators
Marie Carmen Valenza
Principal investigator
Universidad de Granada
Eligibility Criteria
Inclusion Criteria
- •Diagnosis of chronic pelvic pain
- •Moderate fear of movement
Exclusion Criteria
- •Other clinical diagnosis.
- •Other pathology such as neurological disease.
- •Cognitive impairment.
Outcomes
Primary Outcomes
Fear-avoidance behaviors
Time Frame: Baseline, 6 weeks
Changes from baseline to the end of the intervention will be assessed with the Fear Avoidance Beliefs Questionnaire (FABQ) using the physical activity subscale. This subscale focus on patients' beliefs about how physical activity affected their pain. The values ranges from 0 to 24 with higher scores indicating higher levels of fear-avoidance beliefs.
Secondary Outcomes
- Pain assessed by the Brief Pain Inventory(Baseline, 6 weeks)
- Disability(Baseline, 6 weeks)
- Activity performance(Baseline, 6 weeks)